We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
We will guide you from your first visit to the centre, allowing you to find all the departments and make the most of our facilities. Whatever the reason for your visit, we will explain how to get about the hospital.
The Paediatric Neurology Department at the Hospital Vall d’Hebron is specialised in the genetic diagnosis of childhood neurological diseases. It participates in different national and European reference networks (like the URDCat Project, Solve-RD, and the European Reference Network for Rare Neurological Diseases), which centralises a large number of paediatric patients with hereditary dystonia. The genetic studies are carried out in the Paediatric Neurology Laboratory as part of several different research studies, which are funded by national and international entities as well as associations of families affected by dystonia.
Patients who are likely to suffer from dystonia undergo different metabolic, neurophysiological, and neuroimaging tests in order to classify what kind of dystonia they have, before carrying out genetic studies. Next, DNA sequencing studies are performed to establish the genetic origin of the dystonia.
To determine the origin of the patient’s dystonia, which is essential for deciding on a correct course of treatment.
There are many different genetic origins of dystonia. Therefore, diagnosing it requires both conventional and newly developed DNA sequencing techniques.
For patients with myoclonus-dystonia, first, Sanger sequencing is done for the epsilon-sarcoglycan gene, which is responsible for 70% of myoclonus-dystonia cases in children.
For patients with other kinds of dystonia, whole-exome sequencing (on the parents and the patient) or sequencing for the index case (the patient) is done first, depending on the DNA samples available.
There are no risks for the patient.
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to email@example.com, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut.
Purpose: Manage the user’s contact information.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.